Stem Cell Therapy For Lung Diseases

Stem cell therapy advisory the use of stem cells for treating lung diseases has great appeal.

Stem cell therapy for lung diseases.

With stem cell therapy for lung diseases the lungs recover from pulmonary fibrosis the fibrosis scar and stiff the air sacs of the lungs making it harder to breath and reduce the volume of oxygen the lungs are capable of receiving. Cellular therapy prp pc and anti inflammatory initiative for lung disease. Our cellular therapy treatment uses the healing properties in a patient s own blood cells. Stem cell therapy for chronic obstructive pulmonary disease copd or lung disease stem cells have the unique ability to change into any cell in the body called differentiation.

In one animal study researchers did transbronchial biopsies. Lung diseases are extremely common. The blood is taken to our in house laboratory where platelet rich plasma platelet concentrate prp pc and other healing cells are separated and isolated. For lung disease patients whose condition has created advanced levels of structural damage or whose condition is otherwise highly progressed and has created significant degeneration we recommended a larger dose of 200 000 000 300 000 000 stem cells.

They can be administered intravenously and find damaged tissues around organs. For lung disease patients who experience a primarily inflammation based condition and who have not experienced structural damage we typically recommend a minimum package of 100 000 000 stem cells. Adult stem cell therapy for chronic obstructive pulmonary disease and damaged lungs is now possible via lung bioengineering and advancements in cellular biology. The patients are treated with allogenic bone marrow derived mscs and followeded for six months.

This new approach allows up to ameliorate lung injuries and degenerative lung diseases by using therapeutic levels of pulmonary msc cells while increasing its localization and retention. At a treatment session our clinicians perform a small blood draw from the patient s arm. Due to limited opportunities to participate in clinical studies of stem cells in the u s. As we learn more about the therapeutic potential of stem cells and other cell therapies in clinical trials of non lung diseases we hope to be able to move toward further consideration of these approaches in lung diseases.

Currently millions of adults in the united states are living with a respiratory condition or in some situations more than one. Treatment for many common lung diseases is offered at the lung health institute.